How many institutional investors hold MDGL?

5 tracked institutional investors disclosed a position in MDGL (MADRIGAL PHARMACEUTICALS INC) in their most recent 13F filing.

Who is the largest institutional holder of MDGL?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in MDGL, valued at $315M.

Where does this MDGL ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

MDGL — MADRIGAL PHARMACEUTICALS INC

Name: MADRIGAL PHARMACEUTICALS INC (MDGL) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying MDGL?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Strong distribution · 0 buying vs 2 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 2 tracked investors who changed their MDGL position last quarter, 0 bought and 2 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).

Supporting evidence

+5 tracked investors reported holding MDGL at their latest filing

Contradicting evidence — always shown

−2 tracked investors reduced or exited last quarter (1 reduced, 1 sold out)
−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.

About MADRIGAL PHARMACEUTICALS INC (MDGL)

MADRIGAL PHARMACEUTICALS INC (MDGL) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $315M. Across recent filings, tracked investors recorded 1 new positions, 1 increased, 2 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in MDGL

/100

Mixed Activity

Added / Increased2

Reduced2

Exited1

BearishBullish

Crowded Trade Score™

How many top investors track MDGL

/100

Emerging Interest

5investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

MDGL Ownership Composition

How MADRIGAL PHARMACEUTICALS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

74% of tracked value

Institutions

tracked investors

Total Reported

$467.9M

combined 13F value

Other73.7%
Hedge Funds26.3%

Other(4)

73.7%

Hedge Funds(1)

26.3%

Tracked investors reporting MDGL

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	602.5K	$315.4M	0.05%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	234.9K	$123M	0.16%	Mar 31, 2026
Izzy Englander	Millennium Management	40.9K	$21.4M	0.01%	Mar 31, 2026
Paul Tudor Jones	Tudor Investment Corp	11.6K	$6.1M	0.01%	Mar 31, 2026
Ray Dalio	Bridgewater Associates	3.9K	$2.1M	0.01%	Mar 31, 2026

Ken GriffinMar 31, 2026
Citadel Advisors
Shares
602.5K
Value
$315.4M
% Portfolio
0.05%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
234.9K
Value
$123M
% Portfolio
0.16%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
40.9K
Value
$21.4M
% Portfolio
0.01%
Paul Tudor JonesMar 31, 2026
Tudor Investment Corp
Shares
11.6K
Value
$6.1M
% Portfolio
0.01%
Ray DalioMar 31, 2026
Bridgewater Associates
Shares
3.9K
Value
$2.1M
% Portfolio
0.01%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Ken Griffin	Sold	-100.00%	$0	May 15, 2026
Ray Dalio	Reduced	-79.60%	$2.1M	May 15, 2026
Ken Griffin	Increased	7.07%	$107.2K	Feb 17, 2026
Ray Dalio	Reduced	-30.83%	$11.2K	Feb 13, 2026
Ray Dalio	New	—	$12.7K	Nov 13, 2025

Ken Griffin
Sold
$0(-100.00%)May 15, 2026
Ray Dalio
Reduced
$2.1M(-79.60%)May 15, 2026
Ken Griffin
Increased
$107.2K(7.07%)Feb 17, 2026
Ray Dalio
Reduced
$11.2K(-30.83%)Feb 13, 2026
Ray Dalio
New
$12.7KNov 13, 2025

Frequently asked questions

How many institutional investors hold MDGL?: 5 tracked institutional investors disclosed a position in MDGL (MADRIGAL PHARMACEUTICALS INC) in their most recent 13F filing.
Who is the largest institutional holder of MDGL?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in MDGL, valued at $315M.
Did institutional ownership of MDGL increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 1 increased, 2 reduced, and 1 fully exited MDGL.
Where does this MDGL ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.